We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Curious about Albemarle (ALB) Q3 Performance? Explore Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Albemarle (ALB - Free Report) to post quarterly loss of $0.31 per share in its upcoming report, which indicates a year-over-year decline of 111.3%. Revenues are expected to be $1.39 billion, down 40% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 399.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Albemarle metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Net Sales- Energy Storage' at $768.14 million. The estimate suggests a change of -54.7% year over year.
The combined assessment of analysts suggests that 'Net Sales- Ketjen' will likely reach $278.42 million. The estimate indicates a year-over-year change of +6.8%.
According to the collective judgment of analysts, 'Net Sales- Specialties' should come in at $343.99 million. The estimate suggests a change of -2.5% year over year.
Analysts forecast 'Adjusted EBITDA- Specialties' to reach $61.70 million. The estimate is in contrast to the year-ago figure of $46.31 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- Energy Storage' should arrive at $98.74 million. Compared to the present estimate, the company reported $407.48 million in the same quarter last year.
Shares of Albemarle have demonstrated returns of -3.8% over the past month compared to the Zacks S&P 500 composite's +0.4% change. With a Zacks Rank #4 (Sell), ALB is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Curious about Albemarle (ALB) Q3 Performance? Explore Wall Street Estimates for Key Metrics
Wall Street analysts expect Albemarle (ALB - Free Report) to post quarterly loss of $0.31 per share in its upcoming report, which indicates a year-over-year decline of 111.3%. Revenues are expected to be $1.39 billion, down 40% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 399.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some Albemarle metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Net Sales- Energy Storage' at $768.14 million. The estimate suggests a change of -54.7% year over year.
The combined assessment of analysts suggests that 'Net Sales- Ketjen' will likely reach $278.42 million. The estimate indicates a year-over-year change of +6.8%.
According to the collective judgment of analysts, 'Net Sales- Specialties' should come in at $343.99 million. The estimate suggests a change of -2.5% year over year.
Analysts forecast 'Adjusted EBITDA- Specialties' to reach $61.70 million. The estimate is in contrast to the year-ago figure of $46.31 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- Energy Storage' should arrive at $98.74 million. Compared to the present estimate, the company reported $407.48 million in the same quarter last year.
View all Key Company Metrics for Albemarle here>>>
Shares of Albemarle have demonstrated returns of -3.8% over the past month compared to the Zacks S&P 500 composite's +0.4% change. With a Zacks Rank #4 (Sell), ALB is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>